Infusion of Expanded Cord Blood Cells
Pilot Study: Infusion of Off-the-Shelf Ex Vivo Expanded Cryopreserved Progenitor Cells (Dilanubicel) in the Setting of Single Cord Blood Transplantation for Patients With Hematologic Malignancies
More Information
- Trial Status
- Accepting patients
- Trial Phase
- Phase 2
- Enrollment
- 35 patients (estimated)
- Sponsors
- Fred Hutchinson / University of Washington Cancer Consortium
- Collaborators
- National Cancer Institute (NCI), National Heart, Lung, and Blood Institute (NHLBI), Nohla Therapeutics, Inc.
- Tags
- Chemotherapy, Cord Blood, Radiation Therapy
- Trial Type
- Treatment
- Last Update
- 1 day ago
- SparkCures ID
- 1558
- NCT Identifier
- NCT03399773
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print a patient-friendly report to share with your patient.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.